| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/14/2009 | CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/13/2009 | EP2057128A2 Therapeutic substituted hydantoins and related compounds |
| 05/13/2009 | EP2057127A1 Hydantoin derivatives useful as antibacterial agents |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives |
| 05/13/2009 | EP2057114A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 05/13/2009 | EP1788876B1 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof |
| 05/13/2009 | CN101432246A Mono-nitration of aromatic compounds |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486968C Imidazole type functional ion liquid having N-substituted amide structure fragment, and its preparation method |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531577 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse |
| 05/12/2009 | US7531565 Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 05/12/2009 | US7531560 Anti-cytokine heterocyclic compounds |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/07/2009 | WO2009059243A1 Treating and preventing viral infections |
| 05/07/2009 | WO2009038412A3 Beta-secretase inhibiting compounds |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2009009041A3 Compositions and methods for modulating a kinase cascade |
| 05/07/2009 | WO2008103314A3 Methods for modulating bone formation and mineralization |
| 05/07/2009 | US20090118512 Process for Preparing 6,7-Dihydro-5H-Imidazo[1,5-A]Pyridin-8-One |
| 05/07/2009 | US20090118335 Acid Secretion Inhibitor |
| 05/07/2009 | US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP2054380A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | CN101426770A Imidazole derivatives for use as EDG-1 antagonists |
| 05/06/2009 | CN101426769A Five-membered heterocyclic invertebrate pest control agents |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426495A CB1 antagonists and inverse agonists |
| 05/06/2009 | CN101423502A 1-heterocycle-5-phenyl-2amylene-1-ones compounds as well as preparation method and application thereof |
| 05/06/2009 | CN101423501A Heterocycle-containing 5-phenyl-2,4-pentadienyl-1-ones compounds as well as preparation method and application thereof |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/05/2009 | US7528200 Epoxy hardener systems based on aminobis(methylene-ethyleneurea) |
| 05/05/2009 | US7528161 NF-kappaB inhibitors and uses thereof |
| 05/05/2009 | CA2345521C Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
| 04/30/2009 | WO2009055053A2 Diarylhydantoin compounds as androgen receptor modulators |
| 04/30/2009 | WO2009054360A1 Agent for specifically reducing visceral fat |
| 04/30/2009 | WO2009054202A1 Process for producing organic compound and organic compound obtained by the same |
| 04/30/2009 | WO2009053709A1 Process for the preparation of medetomidine |
| 04/30/2009 | WO2007119246A3 An improved process for the manufacture of losartan potassium |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | US20090111864 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer |
| 04/30/2009 | US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| 04/30/2009 | US20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | CA2703635A1 Diarylhydantoin compounds as androgen receptor modulators |
| 04/29/2009 | EP2053046A1 Novel imidazole derivatives |
| 04/29/2009 | EP2053045A1 Novel imidazole derivatives |
| 04/29/2009 | EP2053044A1 Novel imidazole derivatives |
| 04/29/2009 | EP2051966A2 Heterocycles useful as inhibitors of carbonic anhydrase |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421247A Novel imidazole derivatives, preparation and user thereof as medicine |
| 04/29/2009 | CN101418051A Photoinitiator contaning asymmetic hexaaryl bis imidazole and preparation method thereof |
| 04/29/2009 | CN101418020A <99m>Tc marked dimercapto succinate metronidazole esters complex and preparation method and use |
| 04/29/2009 | CN101417980A Metal complex and synthesis and use thereof |
| 04/29/2009 | CN101417979A Protonation alkyl imidazole tungstate ionic liquid and preparation method thereof |
| 04/29/2009 | CN101417978A Method for preparing 1,3-dibenzyl-5-formyl-4-alkoxycarbonyl-imidazoline-2-one |
| 04/29/2009 | CN101417977A Method for synthesizing 1,3-dibenzyl-4,5-cis-dicarboxyl-2-imidazolinone |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524970 Compounds |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524878 Phenyl substituted carboxylic acids |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524867 Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity |
| 04/28/2009 | US7524842 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/28/2009 | US7524435 Using isocyanate dimers, trimer for polyurethanes |
| 04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
| 04/28/2009 | CA2486883C Method of manufacturing sertindole |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009050410A2 Carbene and co<sb>2</sb> adducts and use thereof for co<sb>2</sb> extraction |
| 04/23/2009 | WO2009050352A2 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009049476A1 Process for the manufacture of (+)-biotin |
| 04/23/2009 | WO2008133896A3 Dual-acting antihypertensive agents |
| 04/23/2009 | WO2008095069A3 High stability polyionic liquid salts |
| 04/23/2009 | WO2007019660A3 Azole compounds used as tuberculostatic and leishmanicide agents |
| 04/23/2009 | US20090105324 Imidazole derivatives for use as edg-1 antagonists |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | CA2694377A1 Imidazolone derivatives, preparation method thereof and biological use of same |
| 04/22/2009 | EP2050738A1 Novel imidazolidinone derivative, method of producing the same and method of producing optically active amino acid |
| 04/22/2009 | EP2049107A2 Substituted imidazolone derivatives, preparation and uses |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101412697A Preparation of 1-amino hydantoin derivative hapten, antigen and antibody |
| 04/21/2009 | US7521584 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 04/21/2009 | US7521564 Heterocyclic borane and carborane salt ingredients for use as energetic, high density propellant fuels and fuel additives, or for gas generator and hydrogen storage applications. comprised of both aromatic and non-aromatic heterocyclic cations with the necessary borane and/or carborane anions |